Yumanity Therapeutics Inc (YMTX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

40 GUEST STREET BOSTON, MA 02135

Yumanity Therapeutics is a clinical-stage biopharmaceutical company dedicated to accelerating the revolution in the treatment of neurodegenerative diseases through its scientific foundation and drug discovery platform. The Company's most advanced product candidate, YTX-7739, is currently in Phase 1 clinical development for Parkinson's disease. Yumanity's drug discovery platform is designed to enable the Company to rapidly screen for potential disease-modifying therapies by overcoming toxicity of misfolded proteins in neurogenerative diseases. Yumanity's pipeline consists of additional programs focused on Lewy body dementia, multi- system atrophy, amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), frontotemporal lobar dementia (FTLD), and Alzheimer's disease.

Data as of 2021-07-19 09:33:27 -0400
Market Cap100.495 Million Shares Outstanding10.203 Million Avg 30-day Volume66.449 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-2.57 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.60083 52-week High/Low23.47 / 0.9384 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from YMTX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding YMTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding YMTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PETERS RICHARD PRESIDENT AND CEO

  • Officer
  • Director
56,423 2021-07-02 4

SMITH DEVIN WHITTEMORE SVP AND GENERAL COUNSEL

  • Officer
0 2021-06-14 2

KELLY JEFFERY W.

  • Director
14,800 2021-06-02 3

DRAPKIN KIMBERLEE C

  • Director
14,800 2021-06-02 1

ARKOWITZ DAVID

  • Director
14,800 2021-06-02 2

HEYMAN RICHARD A.

  • Director
14,800 2021-06-02 4

ALLEN PATRICIA L

  • Director
14,800 2021-06-02 3

PICKETT CECIL B

  • Director
14,800 2021-06-02 4

ZYDOWSKY LYNNE

  • Director
14,800 2021-06-02 3

VERMA AJAY EVP, HEAD OF R&D

  • Officer
84,000 2021-04-13 2

COLES N ANTHONY EXECUTIVE CHAIR

  • Officer
  • Director
78,650 2021-04-01 4

EPSTEIN MARIE PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2021-02-01 3

MOHSEN PAULASH CHIEF BUSINESS OFFICER

  • Officer
41,093 2021-02-01 3

ROBERTSON BRIGITTE CHIEF MEDICAL OFFICER

  • Officer
0 2021-02-01 3

SUSAN L. LINDQUIST FAMILY TRUST

SUSAN L. LINDQUIST EXEMPT MARITAL TRUST

SUSAN L. LINDQUIST MASSACHUSETTS NON-EXEMPT MARITAL TRUST

SUSAN L. LINDQUIST MASSACHUSETTS ONLY MARITAL TRUST

  • 10% Owner
1,184,561 2020-12-22 1

BERGER FRANKLIN M

  • Director
0 2020-06-29 0

DULAC EMMANUEL

  • Director
0 2020-06-29 0

CHOWDHURY BADRUL A.

  • Director
0 2020-06-29 0

ALFIERI MICHAEL INTERIM HEAD OF FINANCE

  • Officer
0 2020-05-12 0

CHHABRA MEENU PRESIDENT AND CEO

  • Officer
  • Director
0 2020-03-02 0

MUNOZ BENITO CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-03-02 0

ZECEVIC MARIJA CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-03-02 0

GILMARTIN GEOFFREY S. CHIEF MEDICAL OFFICER

  • Officer
0 2020-03-02 0

WILSON SHEILA CHIEF OPERATING OFFICER

  • Officer
0 2020-03-02 0

LARSON ERIC D SEE REMARKS

  • Officer
0 2020-03-02 0

NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP

NEA PARTNERS 12, LIMITED PARTNERSHIP

NEA 12 GP, LLC

BARRIS PETER J

BASKETT FOREST

KERINS PATRICK J

SANDELL SCOTT D

  • 10% Owner
No longer subject to file 2019-11-26 0

LEE PO SHUN SEE REMARKS

  • Officer
0 2019-03-01 0

ZIMMERMAN SANDRA M. SEE REMARKS

  • Officer
0 2018-08-06 0

BARRETT M JAMES

  • Director
  • 10% Owner
0 2018-06-15 0

RABINOWITZ ERIC

  • Director
0 2018-06-15 0

BOUDREAU HELEN M CHIEF FINANCIAL OFFICER

  • Officer
0 2018-03-01 0

CORMORANT ASSET MANAGEMENT, LLC

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE GP, LLC

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

  • Director
  • 10% Owner
No longer subject to file 2017-12-14 0

HAGEN BRETT R SEE REMARKS

  • Officer
0 2017-04-03 0

FMR LLC

  • SEE REMARK 1
No longer subject to file 2017-03-13 0

NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP

NEA PARTNERS 12, LIMITED PARTNERSHIP

NEA 12 GP, LLC

BARRIS PETER J

BASKETT FOREST

KERINS PATRICK J

KOLLURI KRISHNA KITTU

SANDELL SCOTT D

  • 10% Owner
3,554,610 2016-09-14 0

DETORE JAMES M. SEE REMARKS

  • Officer
0 2016-08-04 0

NOVARTIS BIOVENTURES LTD

NOVARTIS AG

  • 10% Owner
No longer subject to file 2016-02-17 0

MIRABELLI CHRISTOPHER

HEALTHCARE VENTURES VIII, L.P.

CAVANAUGH JAMES H

HEALTHCARE PARTNERS VIII, LLC

HEALTHCARE PARTNERS VIII, L.P.

LAWLOR AUGUSTINE

LITTLECHILD JOHN W

WERNER HAROLD R

  • Director
  • 10% Owner
2,149,295 2016-02-17 0

MIRZAC ROMEO PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2016-02-10 0

WALSHE CONOR M

  • Director
0 2016-02-10 0

ELAN SCIENCE ONE LTD

  • 10% Owner
0 2016-02-10 0

WALSH CHRISTOPHER T PHD

  • Director
0 2016-02-10 0

THIBAULT LANCE E SEE REMARKS

  • Officer
0 2016-02-10 0

SMART JANET L SEE REMARKS

  • Officer
0 2016-02-10 0

MIRABELLI CHRISTOPHER

  • Director
  • 10% Owner
0 2016-02-10 0

PERRIGO CO PLC

PERRIGO HOLDINGS LTD.

ELAN PHARMA INTERNATIONAL LTD.

PERRIGO CORP LTD.

PERRIGO SCIENCE ONE LTD.

  • 10% Owner
2,908,067 2016-02-10 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PETERS RICHARD - Director - Officer PRESIDENT AND CEO

2021-07-07 16:44:43 -0400 2021-07-06 F 79 $10.79 d 56,423 direct 7.9179 0.0 10.9482 3 -0.782 5

PETERS RICHARD - Director - Officer PRESIDENT AND CEO

2021-07-07 16:44:43 -0400 2021-07-02 F 4,441 $11.11 d 56,502 direct 7.9179 0.0 10.9482 3 -0.782 5

SMITH DEVIN WHITTEMORE - Officer SVP AND GENERAL COUNSEL

2021-06-16 17:14:49 -0400 2021-06-14 A 58,400 a 58,400 direct

DRAPKIN KIMBERLEE C - Director

2021-06-04 16:05:49 -0400 2021-06-02 A 14,800 a 14,800 direct

KELLY JEFFERY W. - Director

2021-06-04 16:05:36 -0400 2021-06-02 A 14,800 a 14,800 direct

HEYMAN RICHARD A. - Director

2021-06-04 16:05:27 -0400 2021-06-02 A 14,800 a 14,800 direct

ZYDOWSKY LYNNE - Director

2021-06-04 16:05:16 -0400 2021-06-02 A 14,800 a 14,800 direct

ARKOWITZ DAVID - Director

2021-06-04 16:05:34 -0400 2021-06-02 A 14,800 a 14,800 direct

PICKETT CECIL B - Director

2021-06-04 16:05:13 -0400 2021-06-02 A 14,800 a 14,800 direct

ALLEN PATRICIA L - Director

2021-06-04 16:05:20 -0400 2021-06-02 A 14,800 a 14,800 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 22:15:03 UTC -1.6824 1.7624 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 21:45:03 UTC -1.6796 1.7596 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 21:15:03 UTC -1.6796 1.7596 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 20:45:03 UTC -1.6849 1.7649 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 20:15:05 UTC -1.6849 1.7649 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 19:45:03 UTC -1.6849 1.7649 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 19:15:03 UTC -1.6849 1.7649 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 18:45:03 UTC -1.6849 1.7649 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 18:15:03 UTC -1.6849 1.7649 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 17:45:03 UTC -1.6849 1.7649 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 17:15:02 UTC -1.6849 1.7649 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 16:45:02 UTC -1.6972 1.7772 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 16:15:03 UTC -1.6972 1.7772 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 15:45:02 UTC -1.6972 1.7772 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 15:15:03 UTC -1.6972 1.7772 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 14:45:03 UTC -1.7229 1.8029 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 14:15:03 UTC -1.7229 1.8029 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 13:45:03 UTC -1.7229 1.8029 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 13:15:03 UTC -1.7229 1.8029 100000
YUMANITY THERAPEUTICS INC YMTX 2021-07-23 12:45:03 UTC -1.7229 1.8029 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments